TAC 150 Tablet is a powerful oral antifungal formulation that contains Fluconazole 150 mg as its active ingredient. It is designed to combat a variety of fungal infections by interfering with the fungal cell membrane synthesis, leading to inhibition of fungal growth and eventual cell death. Fluconazole belongs to the class of triazole antifungals, known for its broad-spectrum activity and excellent oral bioavailability.
This tablet is commonly prescribed for treating vaginal yeast infections, oropharyngeal and esophageal candidiasis, systemic candidemia, cryptococcal meningitis, and fungal infections of the skin such as athlete’s foot, jock itch, and ringworm. The 150 mg dose is typically administered as a single dose in cases of uncomplicated vaginal yeast infections, offering both convenience and high efficacy.
Manufactured under stringent quality controls by Bluepill Express, TAC 150 Tablet meets all global pharmacopeial standards. The production process follows WHO-GMP and ISO guidelines, ensuring batch consistency, purity, and therapeutic efficacy. The tablet is formulated for quick absorption and minimal gastrointestinal discomfort, making it well-tolerated among patients.
TAC 150 is also used prophylactically in immunocompromised individuals, such as those undergoing chemotherapy or organ transplantation, where the risk of systemic fungal infection is high. Due to its favorable pharmacokinetic profile, including a long half-life and high tissue penetration, it provides sustained antifungal activity with a single dose.
The product is available in tamper-proof, moisture-resistant packaging to maintain shelf stability and safety. Bluepill Express offers flexible third-party manufacturing solutions for TAC 150, with customizable branding, packaging, and international regulatory support. Full documentation including Certificate of Analysis, Free Sale Certificate, and CTD Dossiers are provided for regulatory submissions across various global markets.
TAC 150 Tablet is trusted by healthcare providers for its reliable clinical performance, minimal side effects, and dosing convenience. With the growing prevalence of fungal infections due to changing climates and lifestyle factors, TAC 150 remains a frontline therapy in both hospital and outpatient settings. Partnering with Bluepill Express ensures high-volume production, global compliance, and seamless export logistics to support your pharmaceutical distribution goals.
Description provided by bluepill express.
FIEO Registered
Export Ready
